[Telaprevir-induced pityriasis rubra pilaris]

MeSH terms

• Adrenal Cortex Hormones / therapeutic use
• Adult
• Antiviral Agents / administration & dosage
• Antiviral Agents / therapeutic use
• Biopsy
• Drug Eruptions / drug therapy
• Drug Eruptions / etiology*
• Drug Eruptions / pathology
• Drug Therapy, Combination
• Eosinophilia / etiology
• Eosinophils / pathology
• Hepacivirus / drug effects
• Hepacivirus / enzymology
• Hepatitis C, Chronic / drug therapy
• Hepatitis C, Chronic / virology
• Histamine Antagonists / therapeutic use
• Humans
• Interferon-alpha / administration & dosage
• Interferon-alpha / therapeutic use
• Keratinocytes / pathology
• Lymphocytes / pathology
• Middle Aged
• Oligopeptides / administration & dosage
• Oligopeptides / adverse effects*
• Oligopeptides / therapeutic use
• Pityriasis Rubra Pilaris / chemically induced*
• Pityriasis Rubra Pilaris / drug therapy
• Pityriasis Rubra Pilaris / pathology
• Polyethylene Glycols / administration & dosage
• Polyethylene Glycols / therapeutic use
• Protease Inhibitors / administration & dosage
• Protease Inhibitors / adverse effects*
• Protease Inhibitors / therapeutic use
• Recombinant Proteins / administration & dosage
• Recombinant Proteins / therapeutic use
• Ribavirin / administration & dosage
• Ribavirin / therapeutic use
• Skin / pathology
• Viral Nonstructural Proteins / antagonists & inhibitors